Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Protagenic Therapeutics Inc (PTIX)

Protagenic Therapeutics Inc (PTIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,197
  • Shares Outstanding, K 4,435
  • Annual Sales, $ 0 K
  • Annual Income, $ -5,000 K
  • 60-Month Beta 0.36
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.74
Trade PTIX with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2000 +11.67%
on 03/18/24
1.8700 -28.34%
on 03/27/24
+0.1900 (+16.52%)
since 03/15/24
3-Month
0.7600 +76.32%
on 01/29/24
1.8700 -28.34%
on 03/27/24
+0.4900 (+57.65%)
since 01/16/24
52-Week
0.6797 +97.15%
on 12/04/23
2.3200 -42.24%
on 05/23/23
-0.3800 (-22.09%)
since 04/14/23

Most Recent Stories

More News
Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th

NEW YORK, NY / ACCESSWIRE / April 26, 2022 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX) a biopharmaceutical company focused on developing drug product candidates to treat stress-related neurologic disorders,...

PTIX : 1.3400 (-4.10%)
Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update

NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to...

PTIXW : 0.0270 (+8.00%)
PTIX : 1.3400 (-4.10%)
Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET

Scientific rationale and evidence for PT00114 in the treatment of Depression, Anxiety, PTSD and A ddiction to be discussed

PTIXW : 0.0270 (+8.00%)
PTIX : 1.3400 (-4.10%)
Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update

NEW YORK, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today...

PTIXW : 0.0270 (+8.00%)
PTIX : 1.3400 (-4.10%)
Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial

NEW YORK, July 23, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today...

PTIXW : 0.0270 (+8.00%)
PTIX : 1.3400 (-4.10%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13th - 15th, 2021. More than 50 companies are scheduled...

ACER : 0.6601 (-17.95%)
ADXN : 21.50 (-13.13%)
AGRX : 0.3820 (+3.13%)
ACOG.VN : 0.240 (unch)
ATGN : 0.7660 (+0.01%)
ABIO : 3.31 (+4.09%)
AUUD : 2.2900 (+20.53%)
BASA : 0.0130 (+4.00%)
BMRA : 0.7550 (-1.95%)
BKTI : 14.00 (+1.52%)
BSFC : 0.0636 (-10.42%)
DTST : 5.03 (-6.16%)
Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10:00 AM ET

NEW YORK, July 06, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today...

PTIXW : 0.0270 (+8.00%)
PTIX : 1.3400 (-4.10%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

RALEIGH, NC / ACCESSWIRE / June 23, 2021 / Access to Giving - an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual...

ACER : 0.6601 (-17.95%)
ADXN : 21.50 (-13.13%)
AGRX : 0.3820 (+3.13%)
ACOG.VN : 0.240 (unch)
ATGN : 0.7660 (+0.01%)
ABIO : 3.31 (+4.09%)
AUUD : 2.2900 (+20.53%)
BASA : 0.0130 (+4.00%)
BKTI : 14.00 (+1.52%)
BSFC : 0.0636 (-10.42%)
DTST : 5.03 (-6.16%)
DCTH : 4.74 (-2.67%)
Protagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th

NEW YORK , June 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a bioharmaceutical company focused on developing drug product candidates to treat stress-related neurologic disorders,...

PTIXW : 0.0270 (+8.00%)
PTIX : 1.3400 (-4.10%)
Protagenic Therapeutics, Inc. Announces Closing of $13.2 Million Public Offering and Uplisting to Nasdaq

New York, April 29, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (NASDAQ:PTIX) ("PTIX" or "Company") today announced the closing of an underwritten public offering of 3,180,000 units at a...

PTIXW : 0.0270 (+8.00%)
PTIX : 1.3400 (-4.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Protagenic Therapeutics, Inc. is a biotechnology company. It focused on the discovery, research and development of novel and naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. Protagenic Therapeutics, Inc., formerly known as Atrinsic, Inc., is based...

See More

Key Turning Points

3rd Resistance Point 1.5314
2nd Resistance Point 1.4857
1st Resistance Point 1.4415
Last Price 1.3400
1st Support Level 1.3516
2nd Support Level 1.3059
3rd Support Level 1.2617

See More

52-Week High 2.3200
Fibonacci 61.8% 1.6934
Fibonacci 50% 1.4999
Last Price 1.3400
Fibonacci 38.2% 1.3063
52-Week Low 0.6797

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar